David Risinger

Leerink Partners | Healthcare

David Risinger is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #1183 out of 4771 analysts, they have issued 18 stock ratings with a success rate of 78.68% and an average return of 38.05%.

With 18 ratings to date, David Risinger is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 78.68% and an average return of 38.05%, highlighting promising potential as their track record develops further.

#1183

Out of 4771

18

Total Ratings

+78.68%

Success Rate

+38.05%

Average Return

Recent Ratings Analysis

LTGO

Sep 01, 2026

Target

$36.00

Current

$21.54

Performance

-3.23%

David Risinger rated LTGO as Outperform on Sep 01, 2026, setting a price target of 36. Shares have remained stable near 21.54, leaving the 36 target still in play.

LLY

Jun 25, 2026

Target

$1232.00

Current

$1123.04

Performance

-0.41%

On Jun 25, 2026, LLY was given a Outperform rating by David Risinger, with a target price of 1232. The stock traded sideways with a -0.41% move, keeping the bullish thesis unresolved.

JNJ

May 13, 2026

Target

$265.00

Current

$266.35

Performance

15.59%

JNJ received a Outperform rating from David Risinger on May 13, 2026, aiming for 265. Momentum has favored the Buy call, with shares climbing from 266.35 to 266.35, rewarding those who trusted the recommendation.

KLRA

May 12, 2026

Target

$36.00

Current

$14.91

Performance

-33.14%

On May 12, 2026, David Risinger published a Outperform outlook on KLRA, with a target of 36. Market action contradicted the Buy thesis, as shares slipped to 14.91.

ANAB

Apr 28, 2026

Target

$85.00

Current

$55.16

Performance

-16.56%

David Risinger on Apr 28, 2026 assigned ANAB a Outperform rating, with a price target of 85. The call has struggled to gain traction, with shares losing 16.56%.

CNTA

Apr 01, 2026

Target

$40.00

Current

$40.50

Performance

1.61%

On Apr 01, 2026, David Risinger reaffirmed CNTA with a Market Perform rating, targeting 40. The neutral call matched muted market action of 1.61%.

ORKA

Mar 16, 2026

Target

$86.00

Current

$91.65

Performance

119.52%

ORKA was rated Outperform by David Risinger on Mar 16, 2026, with a price objective of 86. A bullish response from the market helped close the gap of -5.65 to the target.

AMGN

Feb 04, 2026

Target

$355.00

Current

$382.47

Performance

4.44%

On Feb 04, 2026, David Risinger initiated coverage on AMGN with a Outperform rating and target of 355. Neutral price movement of 4.44% leaves room for interpretation.

BMY

Jan 13, 2026

Target

$60.00

Current

$63.75

Performance

14.00%

David Risinger issued a Outperform recommendation for BMY on Jan 13, 2026, price target set at 60. Investors following the Buy call captured upside momentum, with shares now at 63.75.

VRTX

Dec 29, 2025

Target

$525.00

Current

$514.56

Performance

11.91%

On Dec 29, 2025, VRTX was evaluated by David Risinger, who gave a Outperform rating and target of 525. This case illustrates how a timely bullish rating can translate into tangible gains of 11.91%.

ROIV

Dec 15, 2025

Target

$32.00

Current

$40.94

Performance

86.94%

David Risinger rated ROIV as Outperform on Dec 15, 2025, setting a price target of 32. The call has proven timely, with shares rising 86.94% toward the price target of 32.

XOMA

Dec 11, 2025

Target

$58.00

Current

$40.17

Performance

51.36%

On Dec 11, 2025, XOMA was given a Outperform rating by David Risinger, with a target price of 58. The stock rallied 51.36% after the rating, narrowing the gap to the target of 58 and validating the bullish stance.

IMA

Oct 24, 2025

Target

$30.00

Current

$5.00

Performance

-37.44%

IMA received a Outperform rating from David Risinger on Oct 24, 2025, aiming for 30. The rating hasn’t played out as hoped, with the stock trading 37.44% below expectations.

HALO

Oct 14, 2025

Target

$70.00

Current

$107.00

Performance

60.54%

On Oct 14, 2025, David Risinger published a Market Perform outlook on HALO, with a target of 70. The Hold call missed some of the bullish momentum as shares advanced toward 70.

MTSR

Sep 24, 2025

Target

$57.00

Current

$70.50

Performance

34.29%

David Risinger on Sep 24, 2025 assigned MTSR a Market Perform rating, with a price target of 57. Shares outperformed expectations, climbing 34.29% despite the neutral view.

REGN

Feb 05, 2025

Target

$834.00

Current

$793.26

Performance

10.68%

On Feb 05, 2025, David Risinger reaffirmed REGN with a Outperform rating, targeting 834. The recommendation was supported by strong follow-through as the stock rose from 793.26 to 793.26.

ABBV

Nov 22, 2024

Target

$206.00

Current

$254.98

Performance

44.10%

ABBV was rated Outperform by David Risinger on Nov 22, 2024, with a price objective of 206. A bullish response from the market helped close the gap of -48.98 to the target.

TECX

Nov 11, 2024

Target

$69.00

Current

$28.61

Performance

-37.90%

On Nov 11, 2024, David Risinger initiated coverage on TECX with a Outperform rating and target of 69. The Buy call has yet to be validated as shares remain 40.39 away from the target.

PCVX

Sep 03, 2024

Target

$153.00

Current

$58.90

Performance

-46.53%

David Risinger issued a Outperform recommendation for PCVX on Sep 03, 2024, price target set at 153. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

HLVX

Jul 09, 2024

Target

$2.00

Current

$2.09

Performance

23.67%

On Jul 09, 2024, HLVX was evaluated by David Risinger, who gave a Market Perform rating and target of 2. Investors who stayed in despite the Hold saw upside of 23.67%.

Frequency Asked Questions

Who is David Risinger?

David Risinger is an analyst from Leerink Partners specializing in the Healthcare sector.

What is David Risinger's success rate?

David Risinger currently has a success rate of +78.68%.

How many ratings has David Risinger issued?

David Risinger has issued 18 stock ratings so far.

What is the average return of David Risinger's calls?

Their stock ratings have generated an average return of +38.05%.

What is David Risinger's ranking?

David Risinger is ranked #1183 out of 4771 analysts.

What types of ratings does David Risinger give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Risinger?

You can follow David Risinger by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Risinger?

Their latest rating was a Buy on LTGO issued on 2026-09-01.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep